Systemic sclerosis patients with and without associated pulmonary hypertension can be differentiated based on the serum cytokine expression profile, in which elevated Endostatin in patients with associated pulmonary hypertension is the most promising discriminative factor in this study. This evidence concerns the gene COL18A1 and pulmonary hypertension.